ATE533758T1 - Verfahren zur herstellung von enantiomerenreinem esomeprazol - Google Patents

Verfahren zur herstellung von enantiomerenreinem esomeprazol

Info

Publication number
ATE533758T1
ATE533758T1 AT07827582T AT07827582T ATE533758T1 AT E533758 T1 ATE533758 T1 AT E533758T1 AT 07827582 T AT07827582 T AT 07827582T AT 07827582 T AT07827582 T AT 07827582T AT E533758 T1 ATE533758 T1 AT E533758T1
Authority
AT
Austria
Prior art keywords
methoxy
esomeprazole
pure esomeprazole
camphorsulfonyl
sulfinyl
Prior art date
Application number
AT07827582T
Other languages
English (en)
Inventor
Reddy Bandi Parthasaradhi
Reddy Kura Rathnakar
Reddy Rapolu Raji
Reddy Dasari Muralidhara
Original Assignee
Hetero Drugs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Drugs Ltd filed Critical Hetero Drugs Ltd
Application granted granted Critical
Publication of ATE533758T1 publication Critical patent/ATE533758T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT07827582T 2007-09-25 2007-09-25 Verfahren zur herstellung von enantiomerenreinem esomeprazol ATE533758T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2007/000433 WO2009040825A1 (en) 2007-09-25 2007-09-25 A process for preparation of enantiomerically pure esomeprazole

Publications (1)

Publication Number Publication Date
ATE533758T1 true ATE533758T1 (de) 2011-12-15

Family

ID=40510780

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07827582T ATE533758T1 (de) 2007-09-25 2007-09-25 Verfahren zur herstellung von enantiomerenreinem esomeprazol

Country Status (7)

Country Link
US (1) US7947840B2 (de)
EP (1) EP2106397B1 (de)
AT (1) ATE533758T1 (de)
DK (1) DK2106397T3 (de)
ES (1) ES2375515T3 (de)
PT (1) PT2106397E (de)
WO (1) WO2009040825A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2534144B1 (de) 2010-02-12 2014-09-03 Esteve Química, S.A. Herstellungsverfahren des Natriumsalz von Esomeprazol
CN102285970B (zh) * 2011-09-21 2014-07-23 石药集团欧意药业有限公司 一种埃索美拉唑化合物、制备方法及其药物组合物
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
GB2376231A (en) 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
EP1515963B1 (de) 2002-06-27 2007-02-14 Dr. Reddy's Laboratories Ltd. Verfahren zur herstellung optisch reiner oder optisch angereicherter sulfoxidverbindungen einschliesslich amorphen esomeprazols und dessen salze
US20070060556A1 (en) 2003-05-05 2007-03-15 Yatendra Kumar Barium salt of benzimidazole derivative
ATE437869T1 (de) * 2004-04-28 2009-08-15 Hetero Drugs Ltd Verfahren zur herstellung von pyridinylmethyl-1h- benzimidazolverbindungen in enantiomerenangereicherter form oder als einzelne enantiomere
ATE443051T1 (de) * 2004-10-11 2009-10-15 Ranbaxy Lab Ltd Verfahren zur herstellung substituierter sulfoxide
RU2007145207A (ru) 2005-05-06 2009-06-20 Гленмарк Фармасьютикалз Лимитед (In) Стронциваемая соль эзомепразола, способ ее получения и содержащее ее фармацевтические композиции
KR100641534B1 (ko) * 2005-07-28 2006-11-01 한미약품 주식회사 에스오메프라졸 및 그의 염의 제조방법

Also Published As

Publication number Publication date
DK2106397T3 (da) 2012-01-30
EP2106397A4 (de) 2010-04-07
US20100174087A1 (en) 2010-07-08
WO2009040825A1 (en) 2009-04-02
EP2106397B1 (de) 2011-11-16
ES2375515T3 (es) 2012-03-01
US7947840B2 (en) 2011-05-24
PT2106397E (pt) 2012-01-23
EP2106397A1 (de) 2009-10-07

Similar Documents

Publication Publication Date Title
ATE475655T1 (de) Verfahren zur herstellung von (s)-4- fluormethyldihydrofuran-2-on
AR063710A1 (es) Proceso para la preparacion de acido 6-(3-cloro-2-fluorbencil)-1-[(s)-1-hidroximetil-2-metilpropil]-7-metoxi-4-oxo-1, 4-dihidroquinolon-3-carboxilico como inhibidores de integrasa del hiv e intermediarios de sintesis del mismo y composiciones que lo comprenden.
NZ592827A (en) Methods of preparing quinoline derivatives
TW201129555A (en) Process for the manufacture of dabigatrane etexilate
EP2123636A4 (de) Verfahren zur herstellung eines aminoacetylpyrrolidincarbonitrilderivats
ATE473221T1 (de) 1-(1-benzylpiperidin-4-yl)benzimidazol-5- carbonsäurederivate zur behandlung von diabetes mellitus
ATE539054T1 (de) Verfahren zur herstellung von dihydropyrrolderivaten als zwischenprodukte
MX352470B (es) Disales de acido malonico y metodo para preparar dihaluros de malonilo.
EA201990688A1 (ru) Полиморфные формы соединения, представляющего собой ингибитор киназ, содержащая их фармацевтическая композиция, способ их получения и их применение
EA200900797A1 (ru) Способ синтеза производных 3-аминотетрагидрофуран-3-карбоновой кислоты и их применение в качестве лекарственных средств
ATE518835T1 (de) Kristallform einer chinolinverbindung und verfahren zu deren herstellung
MX2011012479A (es) Moduladores de los receptores 5-ht y metodos de uso de los mismos.
DE602006021411D1 (de) Verfahren zur herstellung von optional 2-substituierten 1,6-dihydro-6-oxo-4-pyrimidincarboxylsäuren
ATE534643T1 (de) Verbessertes verfahren zur herstellung eines optisch aktiven protonenpumpenhemmers
DK2106397T3 (da) Fremgangsmåde til fremstilling af enantiomer-ren esomeprazol
ATE441627T1 (de) Verfahren zur herstellung von valsartan
ATE532516T1 (de) Verfahren zur synthese von glyt-1-hemmern
ATE515496T1 (de) Verfahren zur herstellung von enantiomerenangereicherter indolin-2-carbonsäure
ATE555093T1 (de) Verfahren zur herstellung einer (s)-1-alkyl-2i,6i-pipecoloxylididverbindung
TW200635905A (en) Processes for producing 4-aminoquinazolines
ATE517890T1 (de) Verfahren zur herstellung von reinem irbesartan
DE602005013007D1 (de) Verfahren zur herstellung von lactonen
UA113067C2 (xx) Спосіб одержання хінолінкарбонової кислоти
ATE466010T1 (de) Verfahren zur herstellung von candesartan
DE602007010926D1 (de) Neues verfahren zur herstellung von ammoniumsalzen von esomeprazol

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2106397

Country of ref document: EP